» Articles » PMID: 20609967

Diabetes Mellitus, Fasting Blood Glucose Concentration, and Risk of Vascular Disease: a Collaborative Meta-analysis of 102 Prospective Studies

Overview
Journal Lancet
Publisher Elsevier
Specialty General Medicine
Date 2010 Jul 9
PMID 20609967
Citations 1916
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Uncertainties persist about the magnitude of associations of diabetes mellitus and fasting glucose concentration with risk of coronary heart disease and major stroke subtypes. We aimed to quantify these associations for a wide range of circumstances.

Methods: We undertook a meta-analysis of individual records of diabetes, fasting blood glucose concentration, and other risk factors in people without initial vascular disease from studies in the Emerging Risk Factors Collaboration. We combined within-study regressions that were adjusted for age, sex, smoking, systolic blood pressure, and body-mass index to calculate hazard ratios (HRs) for vascular disease.

Findings: Analyses included data for 698 782 people (52 765 non-fatal or fatal vascular outcomes; 8.49 million person-years at risk) from 102 prospective studies. Adjusted HRs with diabetes were: 2.00 (95% CI 1.83-2.19) for coronary heart disease; 2.27 (1.95-2.65) for ischaemic stroke; 1.56 (1.19-2.05) for haemorrhagic stroke; 1.84 (1.59-2.13) for unclassified stroke; and 1.73 (1.51-1.98) for the aggregate of other vascular deaths. HRs did not change appreciably after further adjustment for lipid, inflammatory, or renal markers. HRs for coronary heart disease were higher in women than in men, at 40-59 years than at 70 years and older, and with fatal than with non-fatal disease. At an adult population-wide prevalence of 10%, diabetes was estimated to account for 11% (10-12%) of vascular deaths. Fasting blood glucose concentration was non-linearly related to vascular risk, with no significant associations between 3.90 mmol/L and 5.59 mmol/L. Compared with fasting blood glucose concentrations of 3.90-5.59 mmol/L, HRs for coronary heart disease were: 1.07 (0.97-1.18) for lower than 3.90 mmol/L; 1.11 (1.04-1.18) for 5.60-6.09 mmol/L; and 1.17 (1.08-1.26) for 6.10-6.99 mmol/L. In people without a history of diabetes, information about fasting blood glucose concentration or impaired fasting glucose status did not significantly improve metrics of vascular disease prediction when added to information about several conventional risk factors.

Interpretation: Diabetes confers about a two-fold excess risk for a wide range of vascular diseases, independently from other conventional risk factors. In people without diabetes, fasting blood glucose concentration is modestly and non-linearly associated with risk of vascular disease.

Funding: British Heart Foundation, UK Medical Research Council, and Pfizer.

Citing Articles

Translating Evidence for a Mediterranean-Style Dietary Pattern into Routine Care for Coronary Heart Disease and Type 2 Diabetes: Implementation and Evaluation in a Targeted Public Health Service in Australia.

Mayr H, Hayes L, Wang W, Murray E, Kelly J, Palmer M Healthcare (Basel). 2025; 13(5).

PMID: 40077068 PMC: 11898626. DOI: 10.3390/healthcare13050506.


Echocardiographic and biomarker characteristics in diabetes, coronary artery disease or both: insights from HOMAGE trial.

Monzo L, Kobayashi M, Ferreira J, Lamiral Z, Delles C, Clark A Cardiovasc Diabetol. 2025; 24(1):111.

PMID: 40057728 PMC: 11890510. DOI: 10.1186/s12933-025-02609-8.


Social and health service-related factors associated with undiagnosed diabetes mellitus- a population-based survey in a highly urbanized Chinese setting.

Poon P, Tam K, Yip B, Chung R, Lee E, Wong S BMC Public Health. 2025; 25(1):900.

PMID: 40050834 PMC: 11887179. DOI: 10.1186/s12889-025-22048-0.


The effectiveness of a community-based online low-glycaemic index diet and lifestyle recommendations intervention for people with type 2 diabetes: a randomized controlled trial.

Chen J, Lv L, Zhao X, Liu Y, Zhong S, Yu G Arch Public Health. 2025; 83(1):61.

PMID: 40045437 PMC: 11884046. DOI: 10.1186/s13690-025-01552-0.


Brazilian guideline for screening and diagnosis of type 2 diabetes: a position statement from the Brazilian Diabetes Society.

Rodacki M, Zajdenverg L, da Silva Junior W, Giacaglia L, Negrato C, Cobas R Diabetol Metab Syndr. 2025; 17(1):78.

PMID: 40038723 PMC: 11881304. DOI: 10.1186/s13098-024-01572-w.


References
1.
Helfand M, Buckley D, Freeman M, Fu R, Rogers K, Fleming C . Emerging risk factors for coronary heart disease: a summary of systematic reviews conducted for the U.S. Preventive Services Task Force. Ann Intern Med. 2009; 151(7):496-507. DOI: 10.7326/0003-4819-151-7-200910060-00010. View

2.
Waltenberger J . Impaired collateral vessel development in diabetes: potential cellular mechanisms and therapeutic implications. Cardiovasc Res. 2001; 49(3):554-60. DOI: 10.1016/s0008-6363(00)00228-5. View

3.
Kelly T, Yang W, Chen C, Reynolds K, He J . Global burden of obesity in 2005 and projections to 2030. Int J Obes (Lond). 2008; 32(9):1431-7. DOI: 10.1038/ijo.2008.102. View

4.
Kanaya A, Grady D, Barrett-Connor E . Explaining the sex difference in coronary heart disease mortality among patients with type 2 diabetes mellitus: a meta-analysis. Arch Intern Med. 2002; 162(15):1737-45. DOI: 10.1001/archinte.162.15.1737. View

5.
Natali A, Vichi S, Landi P, Severi S, LAbbate A, Ferrannini E . Coronary atherosclerosis in Type II diabetes: angiographic findings and clinical outcome. Diabetologia. 2000; 43(5):632-41. DOI: 10.1007/s001250051352. View